Kupperman et al., 1954 - Google Patents
The value of various laboratory procedures in the comparative study of the duration of action of androgensKupperman et al., 1954
View PDF- Document ID
- 17011299005132777830
- Author
- Kupperman H
- Aronson S
- Gagliani J
- Parsonnet M
- Roberts M
- Silver B
- Postiglione R
- Publication year
- Publication venue
- European Journal of Endocrinology
External Links
Snippet
The clinical use of steroid hormones for replacement therapy in hormone deficiency states in the past has necessitated frequent administration of these preparations. Some steroids have been taken orally. However, with the exception of various oestrogenic preparations and …
- 239000003098 androgen 0 title description 42
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/899—Menstrual disorder
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Koch | The male sex hormones | |
Goldzieher et al. | Clinical and biochemical features of polycystic ovarian disease | |
Strauss et al. | The effect of androgens and estrogens on human sebaceous glands | |
Recant et al. | Studies on the effect of epinephrine on the pituitary-adrenocortical system | |
Krüskemper | Anabolic steroids | |
Maddock et al. | The effects of chorionic gonadotropin in adult men: increased estrogen and 17-ketosteroid excretion, gynecomastia. Leydig cell stimulation and seminiferous tubule damage | |
Haskin et al. | Some effects of ACTH, cortisone, progesterone and testosterone on sebaceous glands in the white rat | |
Kenyon et al. | The urinary excretion of androgenic and estrogenic substances in certain endocrine states. Studies in hypogonadism, gynecomastia and virilism | |
Murray et al. | Endocrine changes in male sexual deviants after treatment with anti-androgens, oestrogens or tranquillizers | |
Brown et al. | The effect of norethisterone and its acetate on ovarian and pituitary function during the menstrual cycle | |
SOHVAL et al. | The influence of cortisone and adrenocorticotropin on urinary gonadotropin excretion | |
Callow et al. | The effect of the administration of testosterone propionate on the urinary excretion of compounds allied to the steroid hormones | |
Strauss et al. | The sebaceous glands: twenty-five years of progress | |
Latvalahti | Experimental studies on the influence of certain hormones on the development of amyloidosis | |
Prunty | Hirsutism, virilism and apparent virilism and their gonadal relationship | |
Hoskins et al. | The effect of testosterone propionate on the urinary excretion of androgens and estrogens in eunuchoidism | |
BLISS et al. | The effect of adrenalin on adrenal cortical function | |
Davis et al. | Hormonal interrelationships between maternal adrenal, placental and fetal adrenal functions | |
Dingemanse et al. | The content of male and female hormone in the urine of patients with prostatic hypertrophy | |
Kupperman et al. | The value of various laboratory procedures in the comparative study of the duration of action of androgens | |
MIYAKE et al. | Hormonal influences on the carbonic anhydrase concentration in the accessory reproductive tracts of the rat | |
KEUTMANN et al. | Individual urinary 17-ketosteroids of healthy persons determined by gas chromatography: biochemical and clinical considerations | |
PENTZ et al. | Factors influencing taurine excretion in human subjects | |
Biro et al. | Inhibitory effect of the uterus on plasma and pituitary FSH in rats | |
Barnes et al. | Cyproterone acetate: a study involving two volunteers with idiopathic hirsutism |